BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1645723)

  • 21. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
    Reeve JG; Morgan J; Schwander J; Bleehen NM
    Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and characterization of recombinant chicken insulin-like growth factor-II from Escherichia coli.
    Upton Z; Francis GL; Kita K; Wallace JC; Ballard FJ
    J Mol Endocrinol; 1995 Feb; 14(1):79-90. PubMed ID: 7772242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
    Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
    Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factors are mitogenic for human keratinocytes and a squamous cell carcinoma.
    Neely EK; Morhenn VB; Hintz RL; Wilson DM; Rosenfeld RG
    J Invest Dermatol; 1991 Jan; 96(1):104-10. PubMed ID: 1846163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
    Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
    Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line.
    Nielsen FC; Haselbacher G; Christiansen J; Lake M; Grønborg M; Gammeltoft S
    Mol Cell Endocrinol; 1993 May; 93(1):87-95. PubMed ID: 7686519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suramin inhibits the growth of human rhabdomyosarcoma by interrupting the insulin-like growth factor II autocrine growth loop.
    Minniti CP; Maggi M; Helman LJ
    Cancer Res; 1992 Apr; 52(7):1830-5. PubMed ID: 1312901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding.
    Steele-Perkins G; Roth RA
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1244-51. PubMed ID: 2171510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts.
    Bach LA; Salemi R; Leeding KS
    Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-2 stimulated growth mediated by the somatomedin type 2 receptor.
    Tally M; Li CH; Hall K
    Biochem Biophys Res Commun; 1987 Oct; 148(2):811-6. PubMed ID: 2961329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor receptor expression and function in human breast cancer.
    Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
    Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential stability of recombinant human insulin-like growth factor II in Escherichia coli and Staphylococcus aureus.
    Hammarberg B; Moks T; Tally M; Elmblad A; Holmgren E; Murby M; Nilsson B; Josephson S; Uhlén M
    J Biotechnol; 1990 Jun; 14(3-4):423-37. PubMed ID: 1366914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation.
    Tollefsen SE; Sadow JL; Rotwein P
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1543-7. PubMed ID: 2537977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-level expression of human insulin-like growth factor II in Escherichia coli.
    Rhee HJ; Lee YI; Yang KH
    J Biotechnol; 1990 Mar; 13(4):293-304. PubMed ID: 1366560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of recombinant insulin-like growth factor-II in the development of a radioimmunoassay in rainbow trout (Oncorhynchus mykiss).
    Gentil V; Martin P; Smal J; Le Bail PY
    Gen Comp Endocrinol; 1996 Nov; 104(2):156-67. PubMed ID: 8930606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.
    Lee PD; Rosenfeld RG; Hintz RL; Smith SD
    J Clin Endocrinol Metab; 1986 Jan; 62(1):28-35. PubMed ID: 2999181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical evidence that the type II insulin-like growth factor receptor is identical to the cation-independent mannose 6-phosphate receptor.
    Kiess W; Blickenstaff GD; Sklar MM; Thomas CL; Nissley SP; Sahagian GG
    J Biol Chem; 1988 Jul; 263(19):9339-44. PubMed ID: 2967821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and purification of truncated insulin-like growth factor I from porcine uterus. Evidence for high biological potency.
    Ogasawara M; Karey KP; Marquardt H; Sirbasku DA
    Biochemistry; 1989 Mar; 28(6):2710-21. PubMed ID: 2730884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of affinity-purified type I insulin-like growth factor receptor from human placenta.
    Maly P; Lüthi C
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1257-62. PubMed ID: 3019338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
    McCusker RH; Camacho-Hubner C; Bayne ML; Cascieri MA; Clemmons DR
    J Cell Physiol; 1990 Aug; 144(2):244-53. PubMed ID: 2166057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.